Replimune Group Inc

NASDAQ REPL

Data sourced from

and

Download Data

Replimune Group Inc Cash and Short-Term Investments for the quarter ending March 31, 2024: USD 420.67 M

Replimune Group Inc Cash and Short-Term Investments is USD 420.67 M for the quarter ending March 31, 2024, a -27.89% change year over year. Cash and Short-Term Investments is the sum of cash and short-term investments, representing the company's liquid assets.

Replimune Group Inc Cash and Short-Term Investments for the quarter ending March 31, 2023 was USD 583.39 M, a 47.45% change year over year.
Replimune Group Inc Cash and Short-Term Investments for the quarter ending March 31, 2022 was USD 395.65 M, a -16.93% change year over year.
Replimune Group Inc Cash and Short-Term Investments for the quarter ending March 31, 2021 was USD 476.30 M, a 182.58% change year over year.
Replimune Group Inc Cash and Short-Term Investments for the quarter ending March 31, 2020 was USD 168.56 M, a 25.03% change year over year.

NASDAQ: REPL

Replimune Group Inc

CEO	Mr. Philip Astley-Sparke FSA
IPO Date	July 20, 2018
Location	United States
Headquarters	500 Unicorn Park Drive, Woburn, MA, United States, 01801
Employees	331
Sector	Healthcare
Industry	Biotechnology

Description

Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer. The company's proprietary tumor-directed oncolytic immunotherapy product candidates are designed and intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF, which is in Phase I/II clinical trials for a range of solid tumors. The company is also developing RP2, which is in Phase I clinical trials to express an anti-CTLA-4 antibody-like protein to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3 that is in Phase I clinical trial to express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.

Key trends